GSK PLC ADRhedged
GSKH
2 hedge funds and large institutions have $963K invested in GSK PLC ADRhedged in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
57.57% more ownership
Funds ownership: 0% → 57.57% (+58%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
New York
|
+$928K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.78K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GS
1
GTS Securities
New York
| $961K | +$928K | +17,238 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $1.84K | +$1.78K | +33 | New |
|
GSKH Hedge Fund Activity: Q1 2025 in Review
2 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in GSK PLC ADRhedged (GSKH) for Q1 2025, worth a combined $963K.
Buyers outnumbered sellers: 2 funds opened new GSKH positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was GTS Securities, opening a new position worth an estimated $928K.
- 2 institutional investors held GSK PLC ADRhedged (GSKH) as of Q1 2025, up from 0 in Q4 2024.
- Funds reported $963K of GSK PLC ADRhedged stock for Q1 2025.
- 2 funds opened new GSK PLC ADRhedged positions in Q1 2025 and 0 closed out, a net change of +2 holders.
- The largest GSK PLC ADRhedged buyer in Q1 2025 was GTS Securities, an estimated $928K added.
Based on aggregated 13F filings for Q1 2025.